CLINICAL_TRIALS
research
· 2009-03-03
Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer [Phase 1]
Summary
Phase 1 clinical trial update evaluating a monoclonal antibody therapy for relapsed or refractory small cell lung cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Garden State Cancer Center at the Center for Molecular Medicine and Immunology | Conditions: Lung Cancer | Phase 1 | Status: UNKNOWN